Regular Article
A Novel Strategy for Introducing Exogenous Bcl-2 into Neuronal Cells: The Cre/loxP System-Mediated Activation of Bcl-2 for Preventing Programmed Cell Death Using Recombinant Adenoviruses

https://doi.org/10.1006/mcne.1998.0703Get rights and content

Abstract

We have established a novel strategy for introducing exogenous Bcl-2 into neuronal cells that is mediated by Cre/loxP recombination using recombinant adenoviral vectors. An on/off-switching cassette for Bcl-2 (CALNLbcl-2) was designed to express Bcl-2 by recombinase Cre-mediated excisional deletion of a spacer DNA flanked by a pair ofloxP sites. Exogenous Bcl-2 was clearly induced in PC12 cell lines carrying CALNLbcl-2 after infection with recombinant adenovirus producing recombinase Cre (AxCANCre). Dual infection with both AxCANCre and a recombinant adenovirus bearing CALNLbcl-2 showed efficient delivery of exogenous Bcl-2 into a hybrid motoneuronal cell line and primary chicken spinal motoneurons. The delivery of foreign Bcl-2 promoted survival of motoneurons in medium either containing or lacking trophic support. Thus, this strategy for delivery of exogenous Bcl-2 will be useful for studying neuronal death as well as for introducing foreign genes into postmitotic neurons under the control of recombinase Cre.

References (49)

  • M. Anton et al.

    Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression

    J. Virol.

    (1995)
  • A. Batistatou et al.

    Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: Correlation with suppression of endonuclease activity

    J. Cell Biol.

    (1991)
  • A. Batistatou et al.

    Bcl-2 affects survival but not neuronal differentiation of PC12 cells

    J. Neurosci.

    (1993)
  • B.J. Baumgartner et al.

    Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduction population

    J. Neurosci

    (1997)
  • A. Bilang-Bileuel et al.

    Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease

    Proc. Natl. Acad. Sci. USA

    (1997)
  • L. Bonfanti et al.

    Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2

    J. Neurosci.

    (1996)
  • D.F. Chen et al.

    Bcl-2 promotes regeneration of served axons in mammalian CNS

    Nature

    (1997)
  • J. Chen et al.

    bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations

    Proc. Natl. Acad. Sci. USA

    (1996)
  • D.L. Choi-Lundberg et al.

    Dopaminergic neurons protected from degeneration by GDNF gene therapy

    Science

    (1997)
  • M. Dubois-Dauphin et al.

    Neonatal motoneurons overexpressing thebcl

    Proc. Natl. Acad. Sci. USA.

    (1994)
  • J. Ericson et al.

    Early stages of motor neuron differentiation revealed by expression of homeobox geneIslet

    Science

    (1992)
  • P.G. Farlie et al.

    bcl

    Proc. Natl. Acad. Sci. USA

    (1995)
  • I. Garcia et al.

    Prevention of programmed cell death of sympathetic neurons by thebcl

    Science

    (1992)
  • Y.R.M. Gimenez et al.

    Prevention of motoneuron death by adenovirus-mediated neurotrophic factors

    J. Neurosci. Res

    (1997)
  • Cited by (22)

    • Nerve growth factor protects oligodendrocytes from tumor necrosis factor-α-induced injury through Akt-mediated signaling mechanisms

      2000, Journal of Biological Chemistry
      Citation Excerpt :

      Constitutively active MEK (da-MEK) was subcloned into pAxCAwt (39), an expression cosmid cassette that was created from the human type 5 adenovirus genome from which the E1A, E1B, and E3 regions were deleted and replaced with an expression unit under the control of the CAG promoter (40). The myr-Akt fragment was subcloned into pAxCALNLw, a Cre-inducible expression cassette (41). Akt-AA (Akt T308A/S473A), which contains a hemagglutinin tag at its N terminus and works as a dominant-negative mutant of Akt (42), was kindly provided by Dr. M. Kasuga (Kobe University).

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: (336) 716–4534. E-mail:[email protected].

    View full text